Other OTC Pharmaceuticals (Pharmacies) - NAFTA

NAFTA

Highlights

Revenue in the Other OTC Pharmaceuticals market is projected to reach US$5.36bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.87%, resulting in a market volume of US$5.60bn by 2029.
In global comparison, most revenue will be generated United States (US$4.98bn in 2024).
In relation to total population figures, per person revenues of US$10.50 are generated in 2024.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other OTC Pharmaceuticals (Pharmacies) market in NAFTA is experiencing significant growth and development due to various factors.

Customer preferences: Customers in the NAFTA region have shown a growing preference for over-the-counter (OTC) pharmaceutical products. This can be attributed to several reasons, including the convenience and accessibility of OTC products compared to prescription medications. Additionally, the increasing awareness and emphasis on self-care and preventive healthcare have also contributed to the rise in demand for OTC pharmaceuticals. Customers are increasingly seeking products that can address common health issues and ailments without the need for a doctor's prescription.

Trends in the market: One of the key trends in the Other OTC Pharmaceuticals (Pharmacies) market in NAFTA is the expanding product range. Pharmacies are now offering a wider variety of OTC pharmaceutical products to cater to the diverse needs and preferences of customers. This includes products for pain relief, cough and cold, allergies, digestive health, and skincare, among others. The market is also witnessing a shift towards natural and herbal remedies, as customers are becoming more conscious about the ingredients and potential side effects of traditional pharmaceutical products. Another trend in the market is the increasing adoption of online pharmacies. With the rise of e-commerce and digitalization, customers are now able to purchase OTC pharmaceutical products online, offering them greater convenience and accessibility. Online pharmacies also provide customers with the option to compare prices and read reviews, enabling them to make informed decisions.

Local special circumstances: The Other OTC Pharmaceuticals (Pharmacies) market in NAFTA is influenced by certain local special circumstances. For instance, the regulatory environment plays a crucial role in shaping the market dynamics. Each country within NAFTA has its own regulations and guidelines for the sale and distribution of OTC pharmaceutical products. These regulations can impact the availability and accessibility of certain products, as well as the marketing and advertising practices of pharmacies. Furthermore, consumer behavior and cultural preferences also vary across the NAFTA region. For example, in Mexico, there is a strong tradition of using traditional remedies and herbal medicines, which influences the demand for OTC pharmaceutical products. In contrast, in the United States and Canada, customers are more likely to rely on established brands and products with a proven track record.

Underlying macroeconomic factors: Several macroeconomic factors contribute to the development of the Other OTC Pharmaceuticals (Pharmacies) market in NAFTA. Economic growth and rising disposable incomes play a significant role in driving the demand for OTC pharmaceutical products. As the economy improves, customers have more purchasing power and are willing to spend on healthcare and wellness products. In addition, demographic factors such as an aging population and increasing healthcare costs also impact the market. As the population ages, there is a higher demand for OTC pharmaceutical products to manage chronic conditions and age-related health issues. Moreover, the rising healthcare costs and the burden on the healthcare system have led to a greater emphasis on self-care and preventive measures, further driving the demand for OTC pharmaceuticals. Overall, the Other OTC Pharmaceuticals (Pharmacies) market in NAFTA is experiencing growth and development due to customer preferences for convenience and accessibility, expanding product ranges, the adoption of online pharmacies, local special circumstances, and underlying macroeconomic factors.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.